secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYOMO, INC. (MYO)
CIK:        0001369290
Form:       8-K
Filed at:   2022-08-03T23:59:59+00:00
Accession:  0000950170-22-014246
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myomo Q2 revenue up 18% to $3.7M; record pipeline adds 52% YoY; net loss widens to $0.42/share
--------------------------------------------------------------------------------

- Revenue $3.7M (+18% YoY, +28% seq); product units 80, flat YoY; ASP up via direct billing (83% of revenue).
- Record 420 new patient pipeline adds (+52% YoY); total pipeline 1,049; cost per addition halved from Q4 2021 to ~$2,470.
- Gross margin 65.5%, down 550 bps YoY; net loss $2.9M ($0.42/shr) vs $2.6M ($0.46/shr) in Q2 2021.
- Backlog 163 units (+2% YoY); operating loss $2.9M vs $2.6M; cash $10.2M; entered ELOC with Keystone Capital.
- License payment from China JV delayed; expects sequential Q3 growth but lower YoY revenue; pipeline supports 12-mo outlook.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369290/000095017022014246/0000950170-22-014246-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369290/000095017022014246/myo-20220803.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-014246

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer